Search all trials

Find therapies in clinical trials near you – page 75

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Frexalimab

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Baricitinib

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Bemcentinib

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drug

Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Sibeprenlimab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Squamous cell carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Anaemia+1

Not recruiting

InvestigationalNo placebo

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Ag-946

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

InvestigationalNo placebo

Greece

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Find therapies in clinical trials near you – page 75

964 trials match your criteria

Metastatic malignant melanoma

Study on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases

Systemic lupus erythematosus

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Lung disorder

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Transitional cell carcinoma

Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

IgA nephropathy

Study on Sibeprenlimab for Patients with IgA Nephropathy

Plasma cell myeloma

Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Squamous cell carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Anaemia+1

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Factor VIII deficiency

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.